drugset / Trial / NCT06387862
Pharmacokinetics of Inhaled Levosimendan
Non-randomizedSequentialOpen-labelBasic science
Summary
Determination of biological availability, time-to-peak and elimination half-life of inhaled levosimendan by administration of an inhaled- and intravenous dose of levosimendan.
Timeline
- Start
- 2024-02-01
- Primary completion
- 2024-11
- Completion
- 2025-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levosimendan | Other / unclassified | 12 ug/kg | Inhaled |